134 related articles for article (PubMed ID: 15567954)
1. [Malignant biliary papillomatosis: analysis of p53 expression].
Ahaouche M; Cazals-Hatem D; Watrin T; Arcangeli G; Ruszniewski P; Degott C
Ann Pathol; 2004 Sep; 24(4):364-7. PubMed ID: 15567954
[TBL] [Abstract][Full Text] [Related]
2. Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis.
Amaya S; Sasaki M; Watanabe Y; Tsui WM; Tsuneyama K; Harada K; Nakanuma Y
Histopathology; 2001 Jun; 38(6):550-60. PubMed ID: 11422499
[TBL] [Abstract][Full Text] [Related]
3. Papillary carcinoma with diffuse papillomatosis of gallbladder and cystic duct.
Kosemehmetoglu K; Akpinar E; Sokmensuer C; Hamaloglu E
Ann Diagn Pathol; 2011 Apr; 15(2):140-4. PubMed ID: 20952295
[TBL] [Abstract][Full Text] [Related]
4. Intraductal growth-type mucin-producing peripheral cholangiocarcinoma associated with biliary papillomatosis.
Güllüoglu MG; Ozden I; Poyanli A; Cevikbas U; Ariogul O
Ann Diagn Pathol; 2007 Feb; 11(1):34-8. PubMed ID: 17240305
[TBL] [Abstract][Full Text] [Related]
5. Fine-needle aspiration cytologic diagnosis of intrahepatic biliary papillomatosis (intraductal papillary tumor): report of three cases and comparative study with cholangiocarcinoma.
Tsui WM; Lam PW; Mak CK; Pay KH
Diagn Cytopathol; 2000 May; 22(5):293-8. PubMed ID: 10790236
[TBL] [Abstract][Full Text] [Related]
6. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
7. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
8. Malignant papillomatosis of the intrahepatic bile ducts.
Helpap B
Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):419-25. PubMed ID: 602617
[TBL] [Abstract][Full Text] [Related]
9. Biliary papillomatosis with the point mutation of K-ras gene arising in congenital choledochal cyst.
Ohta H; Yamaguchi Y; Yamakawa O; Watanabe H; Satomura Y; Motoo Y; Okai T; Terada T; Sawabu N
Gastroenterology; 1993 Oct; 105(4):1209-12. PubMed ID: 8405868
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of c-erbB-2 and p53 protein in breast papillomatosis and its malignant transformation].
Tian Y; Li S; Fu X
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):342-5. PubMed ID: 10920912
[TBL] [Abstract][Full Text] [Related]
11. Mucin-producing biliary papillomatosis associated with gastrobiliary fistula.
Ohtsubo K; Ohta H; Sakai J; Mouri H; Nakamura S; Ikeda T; Kifune K; Yoshikawa J; Harada K; Nakanuma Y; Watanabe H; Motoo Y; Okai T; Sawabu N
J Gastroenterol; 1999 Feb; 34(1):141-4. PubMed ID: 10204626
[TBL] [Abstract][Full Text] [Related]
12. Successful photodynamic therapy for biliary papillomatosis: a case report.
Bechmann LP; Hilgard P; Frilling A; Schumacher B; Baba HA; Gerken G; Zoepf T
World J Gastroenterol; 2008 Jul; 14(26):4234-7. PubMed ID: 18636672
[TBL] [Abstract][Full Text] [Related]
13. Biliary tract papillomatosis.
Guglielmi A; Caputi Jambrenghi O; Verzillo F; Cimmino A; De Fazio M; Scardigno A; Memeo V
Minerva Chir; 2001 Oct; 56(5):531-3. PubMed ID: 11568730
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase alpha II, retinoblastoma gene product, and p53: potential relationships with aggressive behavior and malignant transformation in recurrent respiratory papillomatosis.
Gupta D; Holden J; Layfield L
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):86-91. PubMed ID: 11277421
[TBL] [Abstract][Full Text] [Related]
15. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas.
Zen Y; Fujii T; Itatsu K; Nakamura K; Minato H; Kasashima S; Kurumaya H; Katayanagi K; Kawashima A; Masuda S; Niwa H; Mitsui T; Asada Y; Miura S; Ohta T; Nakanuma Y
Hepatology; 2006 Nov; 44(5):1333-43. PubMed ID: 17058219
[TBL] [Abstract][Full Text] [Related]
16. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver.
Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y
Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
18. Well differentiated intrahepatic cholangiocarcinoma in the setting of biliary papillomatosis: a case report and review of the literature.
Cox H; Ma M; Bridges R; Debru E; Bathe O; Sutherland F; Dixon E
Can J Gastroenterol; 2005 Dec; 19(12):731-3. PubMed ID: 16341314
[TBL] [Abstract][Full Text] [Related]
19. Papillomatosis of the intra- and extrahepatic bile ducts with involvement of the pancreatic duct.
Hubens G; Delvaux G; Willems G; Bourgain C; Klöppel G
Hepatogastroenterology; 1991 Oct; 38(5):413-8. PubMed ID: 1765358
[TBL] [Abstract][Full Text] [Related]
20. Invasive biliary cystic tumor without ovarian-like stroma.
Ishibashi Y; Ojima H; Hiraoka N; Sano T; Kosuge T; Kanai Y
Pathol Int; 2007 Dec; 57(12):794-8. PubMed ID: 17988281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
